Enlivex Therapeutics - ADR Financials

$1.09

$-0.02 (-1.80%)

As on 09-Sep-2026 10:36EDT

Market cap

$19 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

0

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	-10.42	-13.01	-23.52	-23.95	-17.54	-11.01
Cash Flow from Investing Activities	-1.32	9.06	-25.97	62.52	-38.41	-20.98
Cash from Financing Activities	10.38	6.45	0.36	0.15	60.98	33.08
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	384.52	-10.29	-1.56	-1.69	-0.79	-0.88
Cash EPS ($)	384.62	-9.91	-1.52	-1.65	-0.76	-0.86
Adjusted Book Value ($)	602.19	16.16	1.62	3.09	4.64	2.64
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-3.24	-8.91	-1.26	-1.30	-0.96	-0.82
Free Cash Flow per Share ($)	-3.26	-8.98	-1.28	-1.74	-1.05	-0.89

Profitability Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	126.09	-54.36	-62.64	-40.67	-22.83	-50.21
ROE (%)	126.17	-55.95	-66.88	-43.78	-24.01	-50.56
ROA (%)	104.94	-46.54	-55.65	-38.16	-21.35	-40.83
EBIT Margin (%)	--	--	--	--	--	-429.73
Net Margin (%)	--	--	--	--	--	-519.28
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	--	--	--	--	-1.00	--
EBIT Growth (%)	0.09	48.32	-12.63	-33.75	-97.12	-13.53
Net Profit Growth (%)	8,329.17	48.35	6.41	-114.68	-22.36	-26.00
EPS Growth (%)	38.38	-5.58	0.07	-1.14	0.10	0.06
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	0.00	-0.11	-1.73	-2.33	-7.91	-9.60
Price / Book Value	0.00	0.07	1.67	1.27	1.35	3.20
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.20	1.47	-0.85	-1.08	-1.94	-8.21
Close Price ($)	10.55	17.55	40.50	59.06	93.75	126.45
High Price ($)	31.50	68.85	69.75	129.60	441.00	254.10
Low Price ($)	9.90	12.15	18.00	54.30	84.45	53.85
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	0.00	0.02	0.03	0.09	0.07	0.01
Short term debt to equity ratio	0.00	0.01	0.01	0.01	0.01	0.01
Current Ratio	193.24	6.84	5.57	7.92	18.32	8.72
Quick Ratio	--	--	5.61	7.74	20.91	15.86
Interest Coverage	-1,153.85	-1,154.92	-2,075.29	-4.90	-58.80	-1,630.83

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	--	--	54.59
Asset Turnover	--	--	--	--	--	0.08
Receivable days	--	--	--	--	--	292.42
Inventory Days	--	-153.47	207.34	-2,591.54	-14,516.68	-18,963.63
Payable days	2,540.80	548.88	606.93	664.22	448.54	497.43
Cash Conversion Cycle	--	--	--	--	--	-19,168.63